日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer

VEGF信号复杂性导致EGFR酪氨酸激酶抑制剂耐药的非小细胞肺癌对阿特珠单抗、贝伐珠单抗、卡铂和紫杉醇产生耐药性

Hong, Sehwa; Yu, Namhee; Cho, Ju Young; Lee, Geon Kook; Ahn, Beung-Chul; Lee, Youngjoo; Sim, Hanna; Song, Bo Ram; Hwang, Mihwa; Kim, Sunshin; Kim, Jung-Hyun; Park, Charny; Han, Ji-Youn

Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma

蛋白质组学表征可识别 EGFR 和 ALK 野生型非吸烟者肺腺癌的临床亚组

Hyondeog Kim #, Wonyeop Lee #, Youngwook Kim #, Sang-Jin Lee, Wonyoung Choi, Geon Kook Lee, Seung-Jin Park, Shinyeong Ju, Seon-Young Kim, Cheolju Lee, Ji-Youn Han

Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy

患者来源肺癌细胞的药物反应可预测靶向治疗的临床结果

Kim, Sunshin; Lee, Youngjoo; Song, Bo Ram; Sim, Hanna; Kang, Eun Hye; Hwang, Mihwa; Yu, Namhee; Hong, Sehwa; Park, Charny; Ahn, Beung-Chul; Lim, Eun Jin; Hwang, Kum Hui; Park, Seog-Yun; Choi, Jin-Ho; Lee, Geon Kook; Han, Ji-Youn

Tumor Microenvironment Modulation by Neoadjuvant Erlotinib Therapy and Its Clinical Impact on Operable EGFR-Mutant Non-Small Cell Lung Cancer

新辅助厄洛替尼治疗对肿瘤微环境的调控及其对可手术EGFR突变型非小细胞肺癌的临床影响

Ahn, Beung-Chul; Park, Charny; Kim, Moon Soo; Lee, Jong Mog; Choi, Jin Ho; Kim, Hyae Young; Lee, Geon Kook; Yu, Namhee; Lee, Youngjoo; Han, Ji-Youn

Detailed characterization of combination treatment with MET inhibitor plus EGFR inhibitor in EGFR-mutant and MET-amplified non-small cell lung cancer

对 MET 抑制剂联合 EGFR 抑制剂治疗 EGFR 突变和 MET 扩增的非小细胞肺癌的详细表征

Lee, Youngjoo; Park, Seog-Yun; Lee, Geon Kook; Lim, Hyun-Ju; Choi, Yu-Ra; Kim, Jaemin; Han, Ji-Youn

Nivolumab after Induction Chemotherapy in Previously Treated Non-Small-Cell Lung Cancer Patients with Low PD-L1 Expression

在既往接受过治疗且PD-L1表达低的非小细胞肺癌患者中,诱导化疗后使用纳武利尤单抗治疗

Ahn, Beung-Chul; Park, Charny; Lee, Sang-Jin; Hong, Sehwa; Hwang, Ji-Eun; Kwon, Kyoungsuk; Kim, Jin Young; Kim, Kyung-Hee; Kim, Hyae Young; Lee, Geon Kook; Lee, Youngjoo; Han, Ji-Youn

A Randomized Phase II Study of Irinotecan Plus Cisplatin with or without Simvastatin in Ever-Smokers with Extended Disease Small Cell Lung Cancer

一项随机II期研究,比较伊立替康联合顺铂加或不加辛伐他汀治疗既往吸烟且病情进展期小细胞肺癌患者的疗效

Lee, Youngjoo; Lee, Soo-Hyun; Lee, Geon Kook; Lim, Eun Jin; Han, Ji-Youn

Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance

铂类耐药小细胞肺癌的分子亚型及肿瘤微环境特征

Jihyun Kim, Sunshin Kim, Seog-Yun Park, Geon Kook Lee, Kun Young Lim, Jin Young Kim, Jung-Ah Hwang, Namhee Yu, Eun Hye Kang, Mihwa Hwang, Bo Ram Song, Charny Park, Ji-Youn Han

Usefulness of BRAF VE1 immunohistochemistry in non-small cell lung cancers: a multi-institutional study by 15 pathologists in Korea

BRAF VE1免疫组化在非小细胞肺癌中的应用价值:韩国15位病理学家开展的多中心研究

Chang, Sunhee; Choi, Yoon-La; Shim, Hyo Sup; Lee, Geon Kook; Ha, Seung Yeon

A fusion of CD63-BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis

在肺腺癌中发现的 CD63-BCAR4 融合促进致瘤性和转移

Kieun Bae, Jin Hee Kim, Hyojik Jung, Sun-Young Kong, Yun-Hee Kim, Sunshin Kim, Geon Kook Lee, Jin Soo Lee, Jake June-Koo Lee, Young Seok Ju, Yang-Kyu Choi, Kyong-Ah Yoon